During this year's RSNA meeting, providers were especially interested in how AI applications could enhance opportunistic screening capabilities.

In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.

With the number of FDA approved AI-enabled applications nearing 1,000, it’s clear the healthcare industry is ready to embrace the evolving technology.

The system combines findings from SPECT myocardial perfusion imaging with lifestyle and clinical factors to predict risk of major cardiovascular events.

The methods enable providers to identify signs of sepsis by assessing blood flow throughout the muscles. 

The scam took place over a period of seven years, resulting in Medicare being billed for more than $70 million in fraudulent claims for unnecessary scans. 

RadNet Inc. presented new research at RSNA 2024, showing that women who paid $40 for an AI add-on experienced a 21% higher breast cancer detection rate. 

California-based Acutus Medical has said its ongoing agreement to manufacture and distribute left-heart access devices for Medtronic is the company's only source of revenue.